NCT02320266

Brief Summary

Deep brain stimulation (DBS) is an FDA approved, and widely used method for treating the motor symptoms of Parkinson's disease (PD), Essential Tremor (ET), Dystonia and Obsessive Compulsive disorder (OCD). Over 100,000 patients worldwide have now been implanted with DBS devices. Current approved methods to locate the DBS target regions in the brain use a combination of stereotactic imaging techniques and measurements of the electrical activity of brain cells. As part of the standard clinical technique, electrical data are collected from individual nerve cells. The target brain region emits unique electrical signals. At certain brain locations, during DBS surgery, additional electrical data that are generated in response to sound will be collected. Regions of the brain that have a decreased response to repeated sound (auditory gating) may be important DBS targets for improving thinking. The aims are (i) during DBS surgery, in addition to EEG, use microelectrodes in the brain to find brain regions, along the normal path to the DBS target, where auditory gating occurs and then (ii) determine if stimulation of the identified region(s) alters auditory gating measured by EEG. Also an additional aim (iii) is to measure electrical activity at the scalp with EEG to characterize auditory gating in patients before and after DBS surgery and also a healthy control population.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

December 16, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

10 years

First QC Date

December 16, 2014

Last Update Submit

May 10, 2024

Conditions

Keywords

Deep Brain Stimulation Surgery

Outcome Measures

Primary Outcomes (3)

  • Changes in EEG (Measurement in response to paired auditory clicks.)

    Measurement in response to paired auditory clicks.

    20 min to 2 hours

  • Evaluation of SUA (Single unit analysis of brain response.)

    Single unit analysis of brain response.

    20 min

  • Evaluation of LFP (Local field potential of brain response.)

    Local field potential of brain response.

    20 min

Study Arms (5)

Parkinson's Disease

Patients diagnosed with Parkinson's Disease undergoing DBS surgery.

Control

Age matched controls without Parkinson's Disease and no history of mental illness.

Essential Tremor

Patients diagnosed with Essential Tremor undergoing DBS surgery.

Dystonia

Patients diagnosed with Dystonia undergoing DBS surgery.

Obsessive-Compulsive disorder

Patients diagnosed with Obsessive-Compulsive disorder undergoing DBS surgery.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects with Parkinson's Disease who are planning to undergo DBS surgery. Age matched controls without Parkinson's Disease or a history of mental illness.

You may qualify if:

  • subjects with Parkinson's Disease planning to undergo DBS surgery
  • subjects without Parkinson's Disease
  • subjects without a history of mental illness.

You may not qualify if:

  • subjects with hearing impairment
  • illicit drug use
  • marijuana use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Parkinson DiseaseEssential TremorDystoniaObsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAnxiety DisordersMental Disorders

Study Officials

  • Judith M Gault, Ph.D.

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2014

First Posted

December 19, 2014

Study Start

December 1, 2014

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

May 13, 2024

Record last verified: 2024-05

Locations